European prize for mobile vaccination units The Netherlands’ mobile vaccination units (prikbussen) have been selected as a best-practice method for the European project ‘Overcoming Obstacles to Vaccination’.
RIVM modelling for COVID-19 reviewed by international experts An international audit committee of scientific experts, commissioned by the RIVM Scientific Advisory Board, reviewed the institute’s COVID-19 data analytics and modelling work. These models and data formed a scientific basis for recommendations by the Outbreak Management Team (OMT) and others on COVID-19 control measures in the Netherlands.
Nearly twice as many cases involving long-term symptoms after COVID-19 Three months after infection with the coronavirus SARS-CoV-2, almost half of people still report one or more long-term symptoms, such as fatigue, difficulty concentrating and loss of smell.
Many more infections, limited increase in hospital admissions In the past week, the number of people who tested positive for COVID-19 in the Netherlands increased by 64% compared to the week before that.
Reported COVID-19 infections are still rising, but less rapidly The number of reported COVID-19 infections continued increasing last week. However, the number of newly reported infections once again rose less quickly than in the week before that.
Coronavirus measures: public support remains high, despite concerns With the rapid increase in infections, people estimate their own risk of becoming infected as higher than it was 6 weeks ago (previously 10%, now 18%).
Novel coronavirus continues to spread unabated The number of reported cases of COVID-19 continues to rise in all regions and in all age groups. The Municipal Public Health Service (GGD) reported that 43,903 people tested positive for COVID-19 in the past week.
Initial results of rapid antigen tests for COVID-19 very promising Two antigen tests for rapid diagnosis of COVID-19, which detect the presence of SARS-CoV-2 virus proteins within 15 minutes after testing, show very promising initial results.